Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P van Meerbeeck

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.
Clinical Lung Cancer|October 16, 2020
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating MoodMick van de Wiel, Sofie Derijcke, Daniella Galdermans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2015
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalitiesBihiyga Salhi, Christel Haenebalcke, Silvia Perez-Bogerd, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyGijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communicationMartin P L Bard, Arjen Amelink, Marina Skurichina, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2014
Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committeeHarvey I Pass, Dorothy Giroux, Catherine Kennedy, et al.
Clinical Lung Cancer|October 16, 2020
Coping Strategy Influences Quality of Life in Patients With Advanced Lung Cancer by Mediating MoodMick van de Wiel, Sofie Derijcke, Daniella Galdermans, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2013
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052)Mary E R O'Brien, Rabab M Gaafar, Sanjay Popat, et al.
Translational Lung Cancer Research|March 26, 2015
ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome itChristian Rolfo, Francesco Passiglia, Marta Castiglia, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2016
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International ParticipationHarvey Pass, Dorothy Giroux, Catherine Kennedy, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2015
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalitiesBihiyga Salhi, Christel Haenebalcke, Silvia Perez-Bogerd, et al.
The Lancet. Oncology|February 1, 2014
Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trialsEfstathios Zikos, Irina Ghislain, Corneel Coens, et al.
The Lancet. Oncology|October 20, 2019
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trialGiovanni L Ceresoli, Joachim G Aerts, Rafal Dziadziuszko, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2006
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyGijsbert W P M Kramer, Catherine L Legrand, Paul van Schil, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Improving the specificity of fluorescence bronchoscopy for the analysis of neoplastic lesions of the bronchial tree by combination with optical spectroscopy: preliminary communicationMartin P L Bard, Arjen Amelink, Marina Skurichina, et al.
Pageof 19